|
Henzen C. Glukokortikoide in Stresssituationen. Schweiz Med Forum 2004;4:1187Đ1191.
Kirschbaum C. Das Stresshormon Cortisol Đ Ein Bindeglied zwischen Psyche und Soma? Hrsg. Kaiser G, Heinrich-Heine-Universität Düsseldorf,
HHU Jahrbuch 2001.
Hellhammer J, Hellhammer D. In: Interventionen in der angewandten Psychologie. Ein neuer Weg in der Stressdiagnostik: Neuropattern.
von Stubbe H & Follmann W (Hrsg). Shaker Verlag 2004; 19Đ26.
Schommer N, Hellhammer D. In: Lehrbuch der Klinischen Psychologie und Psychotherapie. Psychobiologische Beiträge zum Verständnis stressbe-
zogener Erkrankungen. Reinecker H (Hrsg). Hogrefe Verlag GmbH & Co 2003; 4. Auflage.
McEwan BS. Protective and damaging effects of stress mediators. New Engl J Med 1998;338(3):171Đ179.
Rosick ER. Cortisol, Stress, and Health. Life Extension 2005;12:40Đ48.
van der Pompe G, Antoni MH, Heijnen CJ. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in
women with metastatic breast cancer. Psychoneuroendocrinology 1996;21(4):361Đ374.
Wilson RS et al. Proneness to psychological distress is associated with risk of AlzheimerŐs disease. Neurology 2003;61(11):1479Đ1485.
Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathology of stress-related bodily disorders. Psychoneuroendo-
crinology 2000;25(1):1Đ35.
Schulz P, Merck D. Gesundheitsrelevante Korrelate eines erniedrigten Cortisolspiegels: Eine Untersuchung an Angestellten eines dentaltechni-
schen Labors. Z f Gesundheitspsychologie 1997, Band V(1):47Đ62.
Ferrari F et al. Age-related changes of the hypothalamus-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 2001;114(4):
319Đ329.
de Weerth C, Zijl R, Buitelaar J (2003). "Development of cortisol circadian rhythm in infancy". Early Hum Dev 73 (1-2): 39Đ52. doi:10.1016/S0378-3782(03)00074-4. PMID 12932892.
Weber CE (1998) "Cortisol's purpose." Medical Hypotheses 51; 289-292.
Freeman, Scott (2002). Biological Science. Prentice Hall; 2nd Pkg edition (December 30, 2004). ISBN 0-13-218746-9.
Barseghian, G.; Rachmiel, L.; Epps, P. (1982) "Direct Effect of Cortisol and Cortisone on Insulin and Glucagon Secretion". Endocrinology 111: 1648,.
Curry, D.L.; Bennett, L.L. (1973) "Dynamics of Insulin Release by Perfused Rate Pancreas: Effects of Hypophysectomy, Growth Hormone, Adrenocorticotropic Hormone and Hydrocortisone". Endocrinology 93: 602,.
Houck, J.C.; Sharma, V.K.; Patel, Y.M.; Gladner, J.A. (1968) "Induction of Collagenolytic and Proteolytic Activities by AntiInflammatory Drugs in the Skin and Fibroblasts". Biochemical Pharmacology 17: 2081,
Manchester, K.L., "Sites of Hormonal Regulation of Protein Metabolism. p. 229", Mammalian Protein [Munro, H.N., Ed.]. Academic Press, New York. On p273.
Husband, A.J.; Brandon, M.R.; Dascelles, A.K. (1973) "The Effect of Corticosteroid on Absorption and Endogenous Production of Immunoglobulins in Calves". Aust. Journal of Exp. Biol. Med. Sci. 55: 707,.
Posey, W.C.; Nelson, H.S.; Branch, B. and Pearlman, D.S. (1978) "The Effects of Acute Corticosteroid Therapy for Asthma on Serum Immunoglobulin Levels". J. Allergy Clin. Immunol. 62: 340,.
Soffer, L.J.; Dorfman, R.I.; Gabrilove, J.L,. "The Human Adrenal Gland". Febiger, Phil.
Kokshchuk, G.I.; Pakhmurnyi, B.A. (1979) "Role of Glucocorticoids in Regulation of the Acid-Excreting Function of the Kidneys". Fiziol. Z H SSR I.M.I.M. Sechenova 65: 751,.
Tai, Y.; Decker, R.A.; Marnane, W.G.; Charney, A.N.; Donowitz, M. (1981) "Effects of Methylprednisolone on Electrolyte Transport by Rat Ileum in Vitro." American Journal of Physiology 240-G346: 70,.
Sandle, G.I.; Keir, M.G.; Record, CO. (1981) "The Effect of Hydrocortisone on the Transport of Water, Sodium, and Glucose in the Jejunum". Scandinavian Journal of Gastroenterol. 16: 667,.
Mason, P.A.; Fraser, R.; Morton, J.J. (1977) "The Effect of Sodium Deprivation and of Angiotensin II Infusion on the Peripheral Plasma Concentration of 18 Hydroxycorticosterone, Aldosterone, and Other Corticosteoids in Man". Steroid Biochemistry 8: 799,
Gorbman, A.; Dickhoff, W.W.; Vigna, S.R.; Clark, N.B.; Muller, A.F,. "Comparative Endocrinology". John Wiley and Sons, New York.
Muller AF Oconnor CM, ed. (1958) "An International Symposium on Aldosterone", page 58. Little Brown & Co.
Knight, R.P., Jr.; Kornfield, D.S.; Glaser, G.H. & Bondy, P.K. (1955) "Effects of Intravenous Hydrocortisone on Electrolytes in Serum and Urine in Man". Journal of Clinical Endocrinology 15: 176-181,.
Barger, A.C.; Berlin, R.D.; Tulenko, J.F. (1958) "Infusion of Aldosterone, 9 Alpha Fluorohydrocortisone, and Antidiuretic Hormone into the Renal Artery of Normal and Adrenalectomized Unanesthetized Dogs: Effect on Electrolyte and Water Excretion". Endocrine. 62: 804,.
Sandle, G.I.; Keir, M.G.; Record, CO. (1981) "The Effect of Hydrocortisone on the Transport of Water, Sodium, and Glucose in the Jejunum". Scandinavian Journal of Gastroenterol. 16: 667,.
Boykin, J.; de Torrent, A.; Erickson, A.; Robertson, G.; Schrier, R.W. (1978) "Role of Plasma Vasopressin in Impaired Water Excretion of Glucocorticoid Deficiency". Journal of Clinical Investigation 62: 738,.
Dingman, J.F.; Gonzalez-Auvert Ahmed, A.B.J.; Akinura, A. (1965) "Antidiuretic Hormone in Adrenal Insufficiency". Journal of Clinical Investigation 44: 1041,.
Weber, C.E (1984). "Copper Response to Rheumatoid Arthritis". Medical Hypotheses 15: 333-348, on p337,.
Weber, C.E. (1984) "Copper Response to Rheumatoid Arthritis". Medical Hypotheses 15: 333,.on p334.
Flohe, L.; Beckman, R.; Giertz, H.; Loschen, G. "Oxygen Centered Free Radicals as Mediators of Inflammation. p. 405", Oxidative Stress (Sies H, ed) Academic Press, New York.
Piletz, J.E.; Herschman, H.R. (1983) "Hepatic Metallothionein Synthesis in Neonatal
Mottled-Brindled Mice". Biochem. Genet. 21: 465.
Chambers, J.W.; Georg, R.H. and Bass, A.D. (1965) "Effect of Hydrocortisone and Insulin on Uptake of Alpha Aminoisobutyric Acid by Isolated Perfused Rat Liver". Mol. Pharmacol. 1: 66,.
Palacios R., Sugawara I. (1982). "Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor". Scand J Immunol 15 (1): 25Đ31. doi:10.1111/j.1365-3083.1982.tb00618.x. PMID 6461917.
Onsrud M Thorsby E (1981) "Influence of in vivo hydrocortisone on some blood lymphocyte subpopulations 1. effect on natural killer cell activity". Scand. J. Immunol. 13; 573-579.
Knight, R.P., Jr. Kornfield, D.S. Glaser, G.H. Bondy, P.K. (1955). "Effects of intravenous hydrocortisone on electrolytes of serum and urine in man". J Clin Endocrinol Metab 15 (2): 176Đ81. PMID 13233328.
Newsholme, E.A., Leech, A.R. "Biochemistry for the Medical Sciences. John Wiley & Sons, New York, on p736.
Davies E. Keyon, C.J.; Fraser, R. (1985) "The role of calcium ions in the mechanism of ACTH stimulation of cortisol synthesis." Steroids 45: 557.
Plotsky, P.M.; Sapolsky, Otto S., RM. (1986) "Inhibition of immunoreactive corticotropin releasing hormone secretion into the hypophysial portal circulation by delayed glucocorticoid feedback." Endocrinology 119: 1126,.
Besedovsky, H.O.; Del Rey, A.; Sorkin, E. (1984) "Integration of Activated Immune Cell Products in Immune Endocrine Feedback Circuits." p. 200 in Leukocytes and Host Defense Vol. 5 [Oppenheim, J.J.; Jacobs, D.M., eds]. Alan R. Liss, New York,.
Dvorak, M.; "Plasma 17-Hydroxycorticosteroid Levels in Healthy and Diarrheic Calves." British Veterinarian Journal 127: 372, 1971.
Fairchild, S.L.; Shannon, K.; Kwan, E.; Mishell, R.I. (1984) "T-Cells Derived Glucocorticosteroid Lymphocytes and a T-Cell Hybridoma." Journal of Immunology 132: 821,.
Stith RD McCallum RE (1986) "General effect of endotoxin on glucocorticoid receptors in mammalian tissues. " Circ. Shock 18(4); 301-309.
Mikosha, A.S.; Pushkarov, I.S.; Chelnakova, I.S.; Remennikov, G.Y.A. (1991) "Potassium Aided Regulation of Hormone Biosynthesis in Adrenals of Guinea Pigs Under Action of Dihydropyridines: Possible Mechanisms of Changes in Steroidogenesis Induced by 1,4, Dihydropyridines in Dispersed Adrenocorticytes." Fiziol. [Kiev] 37: 60,.
Mendelsohn, F.A.; Mackie, C. (1975) "Relation of Intracellular K+ and Steroidogenesis in Isolated Adrenal Zona Glomerulosa and Fasciculata Cells." Clinical Sci. Mol. Medical 49: 13,
Ueda Y, Honda M, Tsuchiya M, Watanabe H, Izumi Y, Shiratsuchi T, Inoue T, Hatano M. (1982) "Response of plasma ACTH and adrenocortical hormones to potassium loading in essential hypertension." Jpn Circ J. Apr;46(4):317-22.
Bauman K Muller J 1972 "Effect of potassium on the final status of aldosterone biosynthesis in the rat. I 18-hydroxylation and 18hydroxy dehydrogenation. II beta-hydroxylation." Acta Endocrin. Copenh. 69; I 701-717, II 718-730.
LaCelle PL et al (1964) "An investigation of total body potassium in patients with
rheumatoid arthritis." Proceedings of the Annual Meeting of the American Rheumatism Association, Arthritis and Rheumatism 7; 321.
Araghiniknam J, Chung S, Nelson-White T, et al. Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life Sci 1996;59:147-57.
Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994;343:1479-81.
Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-20.
Gebre-Medhin G, Husebye ES, Mallmin H, et al. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clin Endocrinol (Oxf) 2000;52:775-80.
Barrett-Connor E, von Mźhlen D, Laughlin GA, Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. J Am Geriatr Soc 1999;47:685-91.
Heinz A, Weingartner H, George D, et al. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 1999;89:97-106.
Heuser I, Deuschle M, Luppa P, et al. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 1998;83:3130-3.
Azuma T, Nagai Y, Saito T, et al. The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia. J Neurol Sci 1999;162:69-73.
Ferrando SJ, Rabkin JG, Poretsky L. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: Relation to HIV illness stage and progression over one year. J Acquir Immune Defic Syndr 1999;22:146-54.
Louviselli A, Pisanu P, Cossu E, et al. Low levels of dehydroepiandrosterone sulfate in adult males with insulin-dependent diabetes mellitus. Minerva Endocrinol 1994;19:113-9.
Moriyama Y, Yasue H, Yoshimura M, et al. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J Clin Endocrinol Metab 2000;85:1834-40.
Kźmpfel T, Then Bergh F, Friess E, et al. Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology 1999;70:431-8.
Weinstein RE, Lobocki CA, Gravett S, et al. Decreased adrenal sex steroid in the absence of glucocorticoid suppression in postmenopausal asthmatic women. J Allergy Clin Immunol 1996;97:1-8.
Dunn PJ; Mahood CB; Speed JF; Jury DR. Dehydroepiandrosterone sulphate concentrations in asthmatic patients: pilot study. N Z Med J 1984;97:805-8.
Kuratsune H, Yamaguti K, Sawada M, et al. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1998;1:143-6.
De Becker P, De Meirleir K, Joos E, et al. Dehydroepiandorsterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm Metab Res 1999;31:18-21.
Khalkhali-Ellis Z, Moore TL, Hendrix MJ. Clin Exp Rheumatol 1998;16:753-6.
Hall GM, Perry LA, Spector TD. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann Rheum Dis 1993;52:211-4.
Mateo L, Nolla JM, Bonnin MR, et al. Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995;22:1455-60.
Gaby AR. Dehydroepiandrosterone: biological effects and clinical significance. Altern Med Rev 1996;1:60-9 [review].
Heikkila R, Aho K, Heliovaara M, et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998;57:281-5.
Mileva Zh, Maleeva A, Khristov G. Androstenedione, DHEA sulfate, cortisol, aldosterone and testosterone in bronchial asthma patients. Vutr Boles. 1990;29:84-7 [in Bulgarian].
Reiter WJ, Pycha A, Schatzl G, et al. Serum dehydroepiandrosterone sulfate concentrations in men with erectile dysfunction. Urology 2000;55:755-8.
Hillen T, Lun A, Reischies FM, et al. DHEA-S plasma levels and incidence of Alzheimer's disease. Biol Psychiatry 2000;47:161-3.
Nasman B, Olsson T, Backstrom T, et al. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 1991;30:684-90.
Sunderland T, Merril CR, Harrington MG, et al. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 1989;2:570.
Yanase T, Fukahori M, Taniguchi S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr J 1996;43:119-23.
Birkenhager-Gillesse EG, Derksen J, Lagaay AM. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann N Y Acad Sci 1994;719:543-52.
Schneider LS, Hinsey M, Lyness S. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol Psychiatry 1992;31:205-8.
Gaby AR. Research review. Nutr Healing, 1996;Jan:7.
Casson PR, Buster JE. DHEA replacement after menopause: HRT 200 or nostrum of the '90s? Contemporary OB/GYN 1997;Apr:119-33.
Arlt W, Justl HG, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in healthy young females after dexamethasone suppression. J Clin Endocrinol Metab 1998;83:1928-34.
Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998;280:1565 [letter].
van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 1998;25:285-9.
Markowitz JS, Carson WH, Jackson CW. Possible dihydroepiandrosterone-induced mania. Biol Psychiatry 1999;45:241-2.
Wolf OT, Neumann O, Hellhammer DH, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2263-7.
Bowers LD. Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio. Clin Chem 1999;45:295-6.
Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360.
Orner GA, Mathews C, Hendricks JD, et al. Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout. Carcinogenesis 1995;16:2893-8.
Metzger C, Mayer D, Hoffmann H, et al. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol Pathol 1995;23:591-605.
McNeil C. Potential drug DHEA hits snags on way to clinic. J Natl Cancer Inst 1997;89:681-3.
Jones JA, Nguyen A, Strab M, et al. Use of DHEA in a patient with advanced prostate cancer: a case report and review. Urology 1997;50:784-8.
Zumoff B, Levin J, Rosenfeld RS, et al. Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res 1981;41:3360-3.
Helzlsouer KJ, Gordon GB, Alberg AJ, et al. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 1992;52:1-4.
Dorgan JF, Longcope C, Stephenson HE, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:533-9.
Gordon GB, Bush TL, Helzlsouer KJ, et al. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 1990;50:3859-62.
Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996;88:291-6.
Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
Zumoff B, Levin J, Rosenfeld RS, et al. Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res 1981;41:3360-3.
Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 1997;145:1030-8.
Barrett-Connor E, Friedlander NJ, Khaw KT. Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 1990;50:6571-4.
Bernstein L, Ross RK, Pike MC, et al. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer 1990;61:298-302.
Johannes CB, Stellato RK, Feldman HA, et al. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study. J Clin Epidemiol 1999;52:95-103.
Morales AJ, Haubrich RH, Hwang JY, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 1998;49:421-32.
Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995;274:1926-30.
Heinonen PK, Koivula T, Pystynen P. Decreased serum level of dehydroepiandrosterone sulfate in postmenopausal women with ovarian cancer. Gynecol Obstet Invest 1987;23:271-4.
Schwartz AG. Inhibition of spontaneous breast cancer formation in female C3H (A vy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res 1979;39:1129-32.
Sahelian R. New supplements and unknown, long-term consequences. Am J Natural Med 1997;4:8 [editorial].
Schunkert H, Hense H-W, Andus T, et al. Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample. Am J Hypertens 1999;12:1140-3.
Hautanen A, Manttari M, Manninen V, et al. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis 1994;105:191-200.
Kiechl S, Willeit J, Bonora E, et al. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study). Arterioscler Thromb Vasc Biol 2000;20:1094-100.
Suzuki M, Kanazawa A, Hasegawa M, et al. A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension. Endocr J 1999;46:521-8.
Casson PR, Santoro N, Elkind-Hirsch K, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 1998;70:107-10.
|
